PeptideDB

Mal-PEG6-PFP 1599486-33-5

Mal-PEG6-PFP 1599486-33-5

CAS No.: 1599486-33-5

Mal-PEG6-PFP is a non-cleavable PEG Linker used in the synthesis of ADC. It is composed of a Maleimide group, 4-unit PEG
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Mal-PEG6-PFP is a non-cleavable PEG Linker used in the synthesis of ADC. It is composed of a Maleimide group, 4-unit PEG and a PFP ester.



Physicochemical Properties


Molecular Formula C25H30F5NO10
Molecular Weight 599.498425960541
Exact Mass 599.179
CAS # 1599486-33-5
PubChem CID 77078505
Appearance Typically exists as solid at room temperature
Density 1.4±0.1 g/cm3
Boiling Point 623.0±55.0 °C at 760 mmHg
Flash Point 330.6±31.5 °C
Vapour Pressure 0.0±1.8 mmHg at 25°C
Index of Refraction 1.490
LogP 0.57
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 15
Rotatable Bond Count 23
Heavy Atom Count 41
Complexity 792
Defined Atom Stereocenter Count 0
SMILES

FC1C(=C(C(=C(C=1OC(CCOCCOCCOCCOCCOCCOCCN1C(C=CC1=O)=O)=O)F)F)F)F

InChi Key HDNANNZNASDAGQ-UHFFFAOYSA-N
InChi Code

InChI=1S/C25H30F5NO10/c26-20-21(27)23(29)25(24(30)22(20)28)41-19(34)3-5-35-7-9-37-11-13-39-15-16-40-14-12-38-10-8-36-6-4-31-17(32)1-2-18(31)33/h1-2H,3-16H2
Chemical Name

(2,3,4,5,6-pentafluorophenyl) 3-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro One ligand is for an E3 ubiquitin ligase, and the other is for the target protein; these two ligands are joined by a linker to form PROTACs. The intracellular ubiquitin-proteasome system is utilized by PROTACs to specifically destroy target proteins[1].
References

[1]. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~166.81 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (4.17 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.6681 mL 8.3403 mL 16.6806 mL
5 mM 0.3336 mL 1.6681 mL 3.3361 mL
10 mM 0.1668 mL 0.8340 mL 1.6681 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.